Literature DB >> 20530855

An estimation of the annual effective dose to the Canadian population from medical CT examinations.

Jing Chen1, Deborah Moir.   

Abstract

This study was carried out to assess the annual per capita effective dose from medical diagnostic procedures using computed tomography (CT) in Canada. Relevant data concerning the nature and the frequency of various diagnostic CT examinations were obtained from the reports on Medical Imaging in Canada and Diagnostic Services in Ontario. Doses associated with examinations of different types were based primarily on typical effective doses used in the National Council on Radiation Protection and Measurements Report 160 with considerations of limited dose information surveyed in Canada. The results show that the per capita annual effective dose from diagnostic CT exams was 0.74 mSv in 2006, up from 0.19 mSv in 1991. This significant increase in population radiation dose from CT scans is due mainly to a more than doubling in the examination rate and to a higher radiation dose per procedure from the newer generation of multi-detector CTs.

Mesh:

Year:  2010        PMID: 20530855     DOI: 10.1088/0952-4746/30/2/002

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  3 in total

1.  X-ray population exposure from projection radiology and computed tomography in Emilia-Romagna from 2001 to 2010: comparison of ICRP 60 and ICRP 103 weighting factors.

Authors:  Gaetano Compagnone; Paola Angelini; Sara Domenichelli
Journal:  Radiol Med       Date:  2013-12-12       Impact factor: 3.469

Review 2.  CT utilization--trends and developments beyond the United States' borders.

Authors:  Karen E Thomas
Journal:  Pediatr Radiol       Date:  2011-08-17

3.  Internal calibration for opportunistic computed tomography muscle density analysis.

Authors:  Ainsley C J Smith; Justin J Tse; Tadiwa H Waungana; Kirsten N Bott; Michael T Kuczynski; Andrew S Michalski; Steven K Boyd; Sarah L Manske
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.